Ryan Zeidan
Vorstandsvorsitzender bei Sling Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Ryan Zeidan
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Extinct | Pharmaceuticals: Major | 6 | |
Sling Therapeutics, Inc.
 Sling Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sling Therapeutics, Inc. is a company dedicated to developing impactful and high-quality clinical therapies for patients. Sling Therapeutics is located in Ann Arbor, MI and was founded by Gary D. Hammer. The company's pipeline includes linsitinib, an oral therapy being developed for thyroid eye disease (TED) that has established a safety profile through treatment of over 800 patients. The company is focused on bringing additional treatment options to patients, as well as the ophthalmology, endocrinology, and rare disease communities. Sling Therapeutics welcomes collaboration in this mission. The CEO is Ryan Zeidan.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ryan Zeidan
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Director/Board Member | |
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | General Counsel Founder | |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Marcadia Biotech, Inc.
 Marcadia Biotech, Inc. Pharmaceuticals: MajorHealth Technology Marcadia Biotech, Inc. develops therapeutic products for diabetes and obesity. It is a biopharmaceutical company focuses on developing a broad portfolio of drug candidates for treatment of diabetes and obesity. The company was founded in 2005 and is headquartered in Carmel, IN. | Pharmaceuticals: Major | Director/Board Member | |
| POXEL | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Welltok, Inc.
 Welltok, Inc. Packaged SoftwareTechnology Services Welltok, Inc. is a consumer activation solutions company that improves people's total wellbeing. It offers proprietary data, advanced analytics, software-as-a-service software, and professional services to engage consumers in personalized and rewarding ways to drive action. The company was founded Jeff Cohen, Carlos C. Cardona, Scott Rotermund, Chris Rotermund, Christopher Coloian, Stanley J. Nowak III, Paulo Matos, Patrick D. Mize, and John DiBiasi in 2009 and is headquartered in Denver, CO. | Packaged Software | Director/Board Member | |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Founder | |
| Michigan State University | College/University | Doctorate Degree | |
TPG Capital LLC
 TPG Capital LLC Investment ManagersFinance TPG Capital LLC is a Private Equity firm, a subsidiary of TPG Capital Advisors LLC founded in 1992 by William S. Price and James George Coulter. The firm is headquartered in Fort Worth with additional offices in London and São Paulo. | Investment Managers | Private Equity Investor | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Private Equity Analyst | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin | |
| Tabor College | College/University | Undergraduate Degree | |
| University of Kansas | College/University | Doctorate Degree | |
| University of Michigan | College/University | Undergraduate Degree Corporate Officer/Principal | |
TPG Growth LLC
 TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
Mayne Pharma Ltd.
 Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Other | General Counsel | |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Corporate Officer/Principal | |
The Bar Council
 The Bar Council Miscellaneous Commercial ServicesCommercial Services The Bar Council specializes in advocacy and advisory services, fair access to justice for all, the standards of ethics, equality and diversity across the profession and the development of business opportunities for barristers at home and abroad. The company was founded in 1894 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Université Paris II Panthéon Assas | College/University | Graduate Degree | |
| The Endocrine Society | Corporate Officer/Principal | ||
| Parke-Davis Pharmaceutical Research, Inc. | Corporate Officer/Principal | ||
| Public Health Foundation Enterprises | Director/Board Member | ||
| ARDELYX, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Biotechnology | Compliance Officer | |
| SPERO THERAPEUTICS, INC. | Biotechnology | General Counsel | |
| The University of Michigan Law School | College/University | Graduate Degree Graduate Degree | |
| California ChangeLawyers | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| Tufts University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
dRx Capital AG
 dRx Capital AG Investment ManagersFinance dRx Capital AG (dRx Capital) is a investment arm of Novartis AG founded in 2015 by Valencia Rick. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
TPG Biotech
 TPG Biotech Investment ManagersFinance TPG Biotech (TPG biotech) is a venture capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2002. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Analyst | |
| Bina Farm Center | Director/Board Member | ||
| GENFLOW BIOSCIENCES PLC | Biotechnology | Chairman | |
Enzyvant, Inc.
 Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022. | Pharmaceuticals: Major | General Counsel | |
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| RALLYBIO CORPORATION | Biotechnology | Director/Board Member | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 40 |
| Frankreich | 6 |
| Vereinigtes Königreich | 4 |
| Hong Kong | 2 |
| Australien | 2 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 12 |
| Finance | 7 |
| Commercial Services | 4 |
| Technology Services | 2 |
Operativ
| Corporate Officer/Principal | 30 |
| Director/Board Member | 29 |
| Independent Dir/Board Member | 14 |
| Chief Tech/Sci/R&D Officer | 13 |
| Chairman | 12 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Ryan Zeidan
- Unternehmensverbindungen
